NIH-funded research R01 grant

Investigating how lactate affects Alzheimer's disease progression

Official title: Lactate as a regulator of Alzheimer's pathology

Funded at University of Kentucky · NIH-11135173 · Data updated 2026-11-12

This study is looking at how a substance called lactate affects brain cells in people with Alzheimer's disease, hoping to find ways to slow down the disease by understanding how the brain uses sugar differently when it’s affected by a harmful protein.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Kentucky
NIH-funded
Lab location1 site (Lexington, United States)
Project startMay 15, 2025
Project endMarch 31, 2030
Funding year2025
Award (this year)$759,352
NIH project number1R01AG093847-01
Project IDNIH-11135173 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk for Alzheimer's disease, particularly those showing early signs of cognitive decline or with a family history of the condition.

Less likely to help

Patients with advanced Alzheimer's disease or those without any cognitive impairment may not benefit from this research.

What this research studies

This research aims to explore the role of lactate in the metabolism of microglial cells and its impact on Alzheimer's disease progression. By examining how changes in glucose metabolism occur in the brain, particularly in response to amyloid-beta, the study seeks to identify whether targeting these metabolic shifts can reduce Alzheimer's-related pathology. The researchers will utilize advanced imaging techniques to assess brain glucose uptake and lactate levels, providing insights into the early metabolic changes associated with Alzheimer's. This could help in understanding the protective or damaging effects of these metabolic adaptations.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies that slow down or prevent the progression of Alzheimer's disease.

How similar studies have gone: Previous research has indicated that metabolic alterations play a significant role in Alzheimer's disease, suggesting that this approach could yield valuable insights and potential breakthroughs.

Where this research is happening

  • University of Kentucky
    Lexington, United States
    Active

Researchers

  • Principal investigator: Macauley-Rambach, Shannon L — University of Kentucky
  • Study coordinator: Macauley-Rambach, Shannon L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.